Ibalizumab Biosimilar, Human CD4 Monoclonal Antibody | C058P
$175.00 – $960.00
The research grade ibalizumab biosimilar protein is for research use only (RUO). Recombinant human IgG4 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
- Details & Specifications
- References
- More Offers
Catalog No. | C058P |
---|---|
Product Name | Ibalizumab Biosimilar, Human CD4 Monoclonal Antibody | C058P |
Supplier Name | Syd Labs, Inc. |
Brand Name | Syd Labs |
Synonyms | TMB-355, TNX-355, Ibalizumab-uiyk |
Summary | The monoclonal antibody ibalizumab biosimilar was produced in mammalian cells. |
Isotype | Human IgG4 kappa. |
Specificity/Sensitivity | The monoclonal antibody ibalizumab biosimilar specifically binds to the human CD4 protein. |
Form Of Antibody | 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives. |
Endotoxin | <1 EU/mg of the protein by the LAL method. |
Purity | >95% by SDS-PAGE under reducing conditions and HPLC. |
Shipping | The monoclonal antibody ibalizumab is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, 2 to 8°C as supplied. |
Note | The research grade ibalizumab biosimilar protein is for research use only (RUO). Recombinant human IgG4 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator. |
Order Offline | Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card. |
Description
C058P: Ibalizumab Biosimilar, Human CD4 Monoclonal Antibody
The monoclonal antibody ibalizumab biosimilar was produced in mammalian cells.
Background of Ibalizumab Biosimilar
What is ibalizumab biosimilar research grade? Ibalizumab Biosimilar uses the same protein sequences as the therapeutic antibody ibalizumab which is a non-immunosuppressive humanised monoclonal antibody that binds CD4, the primary receptor for HIV, and inhibits HIV from entering cells. It is a post-attachment inhibitor, blocking HIV from binding to the CCR5 and CXCR4 co-receptors after HIV binds to the CD4 receptor on the surface of a CD4 cell. Post-attachment inhibitors are a subclass of HIV drugs called entry inhibitors.
Syd Labs provides the following in vivo grade recombinant anti-human CD4 monoclonal antibodies:
Clenoliximab biosimilar, research grade, anti-human CD4 monoclonal antibody
Ibalizumab biosimilar, research grade, anti-human CD4 monoclonal antibody
Recombinant Anti-human CD4 monoclonal antibody (Clone: OKT4)
Recombinant Anti-human CD4 monoclonal antibody (Clone: OKT4A)
Recombinant Anti-human CD4 monoclonal antibody (Clone: 13B8.2)
Recombinant Anti-human CD4 monoclonal antibody (Clone: SK3 / Anti-LEU 3a)
Syd Labs provides the following in vivo grade recombinant anti-mouse CD4 monoclonal antibodies:
Recombinant Anti-mouse CD4 monoclonal antibody (Clone: GK1.5)
Syd Labs provides the following recombinant anti-human CD4 monoclonal antibodies for flow cytometry:
Recombinant Anti-human CD4 monoclonal antibody (Clone: OKT4) for flow cytometry
Recombinant Anti-human CD4 monoclonal antibody (Clone: OKT4A) for flow cytometry
Recombinant Anti-human CD4 monoclonal antibody (Clone: 13B8.2) for flow cytometry
Recombinant Anti-human CD4 monoclonal antibody (Clone: SK3 / Anti-LEU 3a) for flow cytometry
Please remember our product information: Ibalizumab Biosimilar, Human CD4 Monoclonal Antibody: C058P Syd Labs